| Celia Tong, MD | |
|
555 N Duke St, Lancaster, PA 17602-2250 | |
| (717) 544-4900 | |
| Not Available |
| Full Name | Celia Tong |
|---|---|
| Gender | Female |
| Speciality | Radiology - Diagnostic Radiology |
| Location | 555 N Duke St, Lancaster, Pennsylvania |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1285163840 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 2085R0202X | Radiology - Diagnostic Radiology | MT214022 (Pennsylvania) | Primary |
| Entity Name | Massachusetts General Physicians Organization Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1801874573 PECOS PAC ID: 2466365820 Enrollment ID: O20031111000434 |
News Archive
Consumption of sodas and other sugar-sweetened beverages (SSBs) fell for both children and adults between 2003 and 2014, according to a new study led by researchers from Harvard T.H. Chan School of Public Health.
Drug discovery company SCYNEXIS, Inc. today presented data supporting an impressive resistance profile for SCY-635—a novel, oral cyclophilin inhibitor being studied for the treatment of hepatitis C virus (HCV) infection. In the study, SCYNEXIS demonstrated that the hepatitis C virus required multiple mutations across two separate proteins in order to establish resistance to SCY-635. The majority of HCV drugs on the market and in development require only one targeted viral mutation to establish resistance.
Yale researchers and collaborators have identified molecules that underlie nerve fiber degeneration in patients with secondary progressive multiple sclerosis (MS), a disease that cripples nearly three million people worldwide. The new findings are the first observations in humans of molecules that contribute to degeneration of nerve fibers.
Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) today announced 12-week results from an ongoing Phase 2b study of VX-509, an investigational oral, selective Janus kinase 3 (JAK3) inhibitor, dosed once or twice daily in people with active rheumatoid arthritis (RA) taking methotrexate
› Verified 1 days ago
| Entity Name | The General Hospital Corporation |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1023049236 PECOS PAC ID: 6507803806 Enrollment ID: O20080313000351 |
News Archive
Consumption of sodas and other sugar-sweetened beverages (SSBs) fell for both children and adults between 2003 and 2014, according to a new study led by researchers from Harvard T.H. Chan School of Public Health.
Drug discovery company SCYNEXIS, Inc. today presented data supporting an impressive resistance profile for SCY-635—a novel, oral cyclophilin inhibitor being studied for the treatment of hepatitis C virus (HCV) infection. In the study, SCYNEXIS demonstrated that the hepatitis C virus required multiple mutations across two separate proteins in order to establish resistance to SCY-635. The majority of HCV drugs on the market and in development require only one targeted viral mutation to establish resistance.
Yale researchers and collaborators have identified molecules that underlie nerve fiber degeneration in patients with secondary progressive multiple sclerosis (MS), a disease that cripples nearly three million people worldwide. The new findings are the first observations in humans of molecules that contribute to degeneration of nerve fibers.
Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) today announced 12-week results from an ongoing Phase 2b study of VX-509, an investigational oral, selective Janus kinase 3 (JAK3) inhibitor, dosed once or twice daily in people with active rheumatoid arthritis (RA) taking methotrexate
› Verified 1 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Celia Tong, MD Po Box 4216, Lancaster, PA 17604-4216 Ph: (717) 394-6028 | Celia Tong, MD 555 N Duke St, Lancaster, PA 17602-2250 Ph: (717) 544-4900 |
News Archive
Consumption of sodas and other sugar-sweetened beverages (SSBs) fell for both children and adults between 2003 and 2014, according to a new study led by researchers from Harvard T.H. Chan School of Public Health.
Drug discovery company SCYNEXIS, Inc. today presented data supporting an impressive resistance profile for SCY-635—a novel, oral cyclophilin inhibitor being studied for the treatment of hepatitis C virus (HCV) infection. In the study, SCYNEXIS demonstrated that the hepatitis C virus required multiple mutations across two separate proteins in order to establish resistance to SCY-635. The majority of HCV drugs on the market and in development require only one targeted viral mutation to establish resistance.
Yale researchers and collaborators have identified molecules that underlie nerve fiber degeneration in patients with secondary progressive multiple sclerosis (MS), a disease that cripples nearly three million people worldwide. The new findings are the first observations in humans of molecules that contribute to degeneration of nerve fibers.
Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) today announced 12-week results from an ongoing Phase 2b study of VX-509, an investigational oral, selective Janus kinase 3 (JAK3) inhibitor, dosed once or twice daily in people with active rheumatoid arthritis (RA) taking methotrexate
› Verified 1 days ago
Dr. Matthew Jason Winfeld, M.D. Radiology Medicare: Accepting Medicare Assignments Practice Location: 555 N Duke St, Lancaster, PA 17602 Phone: 717-544-4900 Fax: 717-544-5907 | |
Patrick Weybright, Radiology Medicare: Accepting Medicare Assignments Practice Location: 555 N Duke St, Suite 3950, Lancaster, PA 17602 Phone: 717-299-4173 | |
Paul T Collura, MD Radiology Medicare: Not Enrolled in Medicare Practice Location: 250 College Ave, Lancaster, PA 17603 Phone: 717-735-8199 | |
Steven A Morales, M.D. Radiology Medicare: Medicare Enrolled Practice Location: 555 N Duke St, Lancaster, PA 17602 Phone: 717-544-4900 Fax: 717-544-5907 | |
Dr. John Briguglio, M.D. Radiology Medicare: Accepting Medicare Assignments Practice Location: 555 N Duke St, Lancaster, PA 17602 Phone: 717-394-6028 Fax: 717-394-9223 | |
Alan Alexander, MD Radiology Medicare: Not Enrolled in Medicare Practice Location: 250 College Ave, Lancaster, PA 17603 Phone: 717-735-8188 | |
Dr. Margarita M Shultz, M.D. Radiology Medicare: Not Enrolled in Medicare Practice Location: 1300 Millersville Pike, Lancaster, PA 17603 Phone: 717-393-5892 Fax: 717-393-3774 |